Clinical trial
Efficacy and Mechanism of Transcutaneous Vagus Nerve Stimulation in the Treatment of Generalized Anxiety Disorder
NCT06134323 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Mechanism of Transcutaneous Vagus Nerve Stimulation in the Treatment of Generalized Anxiety Disorder
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 5, 2023
- Completion date
- September 30, 2025
- Enrollment
- 82 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.